Aromatase inhibitors represent a more direct way of dealing with estrogen in the body. Instead of blocking estrogen at its receptor, these agents have the more direct task of targeting the enzyme responsible (aromatase) for the biosynthesis of estrogen.

By inhibiting this enzyme, circulating levels of estrogen can be efficiently and significantly reduced. This class of drugs seems to be the current area of focus for many in the medical community, as a dependable inhibitor of aromatase can potentially offer more to patients with related forms of cancer than antiestrogenic agents.

Athletes will likewise find that the more recently developed aromatase inhibitors are the most potent remedies available for the prevention of related side effects.

Main Aromatase Inhibitors:

• Aminoglutethimide

• Testolactone (Teslac)

• Anastrozole (Arimidex)

• Letrozole (femara)

• Exemestane (Aromasin)

• Vorozole (Rivizor)

• Formestane (Lentaron)

• Fadrozole (Afema)